{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:35:04Z","timestamp":1782844504292,"version":"3.54.5"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ccc.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T16:42:21Z","timestamp":1599151341000},"page":"753-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Impact of the Opioid Epidemic"],"prefix":"10.1016","volume":"36","author":[{"given":"Eric J.","family":"Lavonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Dezfulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccc.2020.07.006_bib1","series-title":"Annual surveillance report of drug-related risks and outcomes \u2014 United States surveillance special report","author":"Centers for Disease Control and Prevention","year":"2019"},{"issue":"4","key":"10.1016\/j.ccc.2020.07.006_bib2","doi-asserted-by":"crossref","first-page":"e202361","DOI":"10.1001\/jamanetworkopen.2020.2361","article-title":"Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999-2017","volume":"3","author":"Tori","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"17","key":"10.1016\/j.ccc.2020.07.006_bib3","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.2018.2844","article-title":"Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016","volume":"319","author":"Jones","year":"2018","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ccc.2020.07.006_bib4","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.ccc.2020.07.006_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1465-3362.2010.00213.x","article-title":"Estimating the risk of fatal arrhythmia in patients in methadone maintenance treatment for heroin addiction","volume":"30","author":"Butler","year":"2011","journal-title":"Drug Alcohol Rev"},{"issue":"9","key":"10.1016\/j.ccc.2020.07.006_bib6","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.amjmed.2008.04.020","article-title":"Methadone-associated sudden cardiac death?","volume":"121","author":"Kim","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.ccc.2020.07.006_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2015.04.008","article-title":"Predictors of opioid-related death during methadone therapy","volume":"57","author":"Leece","year":"2015","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.ccc.2020.07.006_bib8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0196-0644(05)80933-3","article-title":"The empiric use of naloxone in patients with altered mental status: a reappraisal","volume":"20","author":"Hoffman","year":"1991","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ccc.2020.07.006_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13181-016-0549-5","article-title":"Validation of criteria to guide prehospital naloxone administration for drug-related altered mental status","volume":"12","author":"Friedman","year":"2016","journal-title":"J\u00a0Med Toxicol"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1017\/S0317167100006326","article-title":"Bulbar signs in normal population","volume":"36","author":"Lim","year":"2009","journal-title":"Can J Neurol Sci"},{"issue":"8948","key":"10.1016\/j.ccc.2020.07.006_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(95)90584-7","article-title":"Pharyngeal sensation and gag reflex in healthy subjects","volume":"345","author":"Davies","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/PL00009514","article-title":"Videofluoroscopic evaluation of aspiration with visual examination of the gag reflex and velar movement","volume":"12","author":"Leder","year":"1997","journal-title":"Dysphagia"},{"issue":"6","key":"10.1016\/j.ccc.2020.07.006_bib13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/emj.16.6.444","article-title":"Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Gag reflex and intubation","volume":"16","author":"Mackway-Jones","year":"1999","journal-title":"J\u00a0Accid Emerg Med"},{"issue":"8271","key":"10.1016\/j.ccc.2020.07.006_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(82)92074-8","article-title":"Gag reflex in assessing level of consciousness","volume":"1","author":"Kulig","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2020.07.006_bib15","article-title":"Endotracheal intubation in the pharmaceutical-poisoned patient: a narrative review of the literature","author":"Burket","year":"2020","journal-title":"J\u00a0Med Toxicol"},{"issue":"6","key":"10.1016\/j.ccc.2020.07.006_bib16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/ALN.0000000000000657","article-title":"Effects of morphine and midazolam on pharyngeal function, airway protection, and coordination of breathing and swallowing in healthy adults","volume":"122","author":"H\u00e5rdemark Cedborg","year":"2015","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.ccc.2020.07.006_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1113\/expphysiol.2008.045724","article-title":"Co-ordination of spontaneous swallowing with respiratory airflow and diaphragmatic and abdominal muscle activity in healthy adult humans","volume":"94","author":"H\u00e5rdemark Cedborg","year":"2009","journal-title":"Exp Physiol"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.ccc.2020.07.006_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccc.2020.07.006_bib20","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/add.13027","article-title":"Naloxone\u2014does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin\/opioid overdose","volume":"110","author":"Neale","year":"2015","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.ccc.2020.07.006_bib21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0196-0644(87)80244-5","article-title":"Naloxone-induced pulmonary edema","volume":"16","author":"Schwartz","year":"1987","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s40800-018-0088-x","article-title":"Naloxone-induced non-cardiogenic pulmonary edema: a case report","volume":"5","author":"Jiwa","year":"2018","journal-title":"Drug Saf Case Rep"},{"issue":"5","key":"10.1016\/j.ccc.2020.07.006_bib23","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1378\/chest.120.5.1628","article-title":"Heroin-related noncardiogenic pulmonary edema: a case series","volume":"120","author":"Sporer","year":"2001","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.annemergmed.2019.04.006","article-title":"Pulmonary complications of opioid overdose treated with naloxone","volume":"75","author":"Farkas","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.ccc.2020.07.006_bib26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/emj.2003.009613","article-title":"Naloxone in opioid poisoning: walking the tightrope","volume":"22","author":"Clarke","year":"2005","journal-title":"Emerg Med J"},{"issue":"4","key":"10.1016\/j.ccc.2020.07.006_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1553-2712.1998.tb02707.x","article-title":"Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose","volume":"5","author":"Wanger","year":"1998","journal-title":"Acad Emerg Med"},{"issue":"11","key":"10.1016\/j.ccc.2020.07.006_bib28","doi-asserted-by":"crossref","first-page":"e1914977","DOI":"10.1001\/jamanetworkopen.2019.14977","article-title":"Effect of intranasal vs intramuscular naloxone on opioid overdose: a randomized clinical trial","volume":"2","author":"Dietze","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ccc.2020.07.006_bib29","series-title":"Clinical and regulatory overview of naloxone products intended for use in the community","author":"Jiang","year":"2018"},{"issue":"18_suppl_2","key":"10.1016\/j.ccc.2020.07.006_bib30","doi-asserted-by":"crossref","first-page":"S501","DOI":"10.1161\/CIR.0000000000000264","article-title":"Part 10: special circumstances of resuscitation","volume":"132","author":"Lavonas","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13011-019-0195-4","article-title":"Higher doses of naloxone are needed in the synthetic opioid era","volume":"14","author":"Moss","year":"2019","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.ccc.2020.07.006_bib32","unstructured":"US Drug Enforcement Administration. 2019 Drug Enforcement Administration National Drug Threat Assessment. 2019. Available at: https:\/\/www.dea.gov\/sites\/default\/files\/2020-01\/2019-NDTA-final-01-14-2020_Low_Web-DIR-007-20_2019.pdf. Accessed June 19, 2019."},{"issue":"2","key":"10.1016\/j.ccc.2020.07.006_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/15563650.2016.1253846","article-title":"Do heroin overdose patients require observation after receiving naloxone?","volume":"55","author":"Willman","year":"2017","journal-title":"Clin Toxicol"},{"issue":"4","key":"10.1016\/j.ccc.2020.07.006_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/emermed-2018-207534","article-title":"Incidence of mortality due to rebound toxicity after 'treat and release' practices in prehospital opioid overdose care: a systematic review","volume":"36","author":"Greene","year":"2019","journal-title":"Emerg Med J"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jemermed.2016.09.015","article-title":"Is a prehospital treat and release protocol for opioid overdose safe?","volume":"52","author":"Kolinsky","year":"2017","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.ccc.2020.07.006_bib36","doi-asserted-by":"crossref","first-page":"903172","DOI":"10.1155\/2013\/903172","article-title":"Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients","volume":"2013","author":"Aghabiklooei","year":"2013","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.ccc.2020.07.006_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00003088-197601030-00004","article-title":"The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone","volume":"1","author":"Berkowitz","year":"1976","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"10.1016\/j.ccc.2020.07.006_bib39","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1553-2712.2000.tb01260.x","article-title":"Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule","volume":"7","author":"Christenson","year":"2000","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/acem.13567","article-title":"Hospital observation upon reversal (HOUR) with naloxone: a prospective clinical prediction rule validation study","volume":"26","author":"Clemency","year":"2019","journal-title":"Acad Emerg Med"},{"issue":"5","key":"10.1016\/j.ccc.2020.07.006_bib41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0196-0644(86)80994-5","article-title":"A\u00a0dosing nomogram for continuous infusion intravenous naloxone","volume":"15","author":"Goldfrank","year":"1986","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ccc.2020.07.006_bib42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1164\/arrd.1972.106.3.472","article-title":"Heroin pulmonary edema","volume":"106","author":"Katz","year":"1972","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.ccc.2020.07.006_bib43","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/00000542-199805000-00004","article-title":"Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification","volume":"88","author":"Kienbaum","year":"1998","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.ccc.2020.07.006_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0952-0600(92)90036-G","article-title":"Opiate action in the pulmonary circulation","volume":"5","author":"Hakim","year":"1992","journal-title":"Pulm Pharmacol"},{"issue":"5","key":"10.1016\/j.ccc.2020.07.006_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF01706365","article-title":"Naloxone administration and laryngospasm followed by pulmonary edema","volume":"16","author":"Olsen","year":"1990","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/ajem.2003.50006","article-title":"Patterns of presentation in heroin overdose resulting in pulmonary edema","volume":"21","author":"Sterrett","year":"2003","journal-title":"Am J Emerg Med"},{"issue":"9","key":"10.1016\/j.ccc.2020.07.006_bib47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/emj.2007.048991","article-title":"Acute respiratory distress syndrome induced by oral methadone managed with non-invasive ventilation","volume":"24","author":"Ridgway","year":"2007","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ccc.2020.07.006_bib48","article-title":"Atrial fibrillation after naloxone administration: a rare complication of opioid feversal","volume":"1","author":"Dela Cruz","year":"2017","journal-title":"J\u00a0Emerg Med Trauma Surg Care"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s40800-014-0002-0","article-title":"Ventricular tachycardia after naloxone administration: a drug related complication? case report and literature review","volume":"1","author":"Lameijer","year":"2014","journal-title":"Drug Saf Case Rep"},{"key":"10.1016\/j.ccc.2020.07.006_bib50","unstructured":"Dezfulian C, Orkin A, Maron B, et\u00a0al. Opioid-associated out-of-hospital cardiac arrest: distinctive clinical features and implications for healthcare and public responses: a scientific statement from the American Heart Association. Circulation, in press."},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajem.2012.05.030","article-title":"Brain computed tomographic scan findings in acute opium overdose patients","volume":"31","author":"Jamshidi","year":"2013","journal-title":"Am J Emerg Med"},{"issue":"10","key":"10.1016\/j.ccc.2020.07.006_bib52","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.amjcard.2019.07.068","article-title":"Frequency of cardiovascular events and in-hospital mortality with opioid overdose hospitalizations","volume":"124","author":"Doshi","year":"2019","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.ccc.2020.07.006_bib53","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ccc.2020.07.006_bib54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000503952","article-title":"Bilateral basal ganglia lesions in patients with heroin overdose: a report of two cases","volume":"2019","author":"Hassan","year":"2019","journal-title":"Case Rep Acute Med"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0379-0738(99)00040-7","article-title":"Hypoxic\/ischaemic brain damage, especially pallidal lesions, in heroin addicts","volume":"102","author":"Andersen","year":"1999","journal-title":"Forensic Sci Int"},{"issue":"9535","key":"10.1016\/j.ccc.2020.07.006_bib56","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(06)69173-3","article-title":"QTc prolongation: methadone's efficacy-safety paradox","volume":"368","author":"Krantz","year":"2006","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ccc.2020.07.006_bib57","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/bcp.13326","article-title":"QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings","volume":"83","author":"Isbister","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.ccc.2020.07.006_bib58","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/15563650.2016.1159310","article-title":"Not your regular high: cardiac dysrhythmias caused by loperamide","volume":"54","author":"Wightman","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.ccc.2020.07.006_bib59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jemermed.2017.04.027","article-title":"Loperamide-induced torsades de pointes: a case series","volume":"53","author":"Katz","year":"2017","journal-title":"J\u00a0Emerg Med"},{"issue":"2","key":"10.1016\/j.ccc.2020.07.006_bib60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.annemergmed.2017.04.008","article-title":"Clinical review: loperamide toxicity","volume":"70","author":"Wu","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"10","key":"10.1016\/j.ccc.2020.07.006_bib61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/qjmed\/hcm072","article-title":"Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram","volume":"100","author":"Chan","year":"2007","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.ccc.2020.07.006_bib62","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/heart.89.5.577","article-title":"Injection drug use and right sided endocarditis","volume":"89","author":"Moss","year":"2003","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ccc.2020.07.006_bib63","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(19)30705-4","article-title":"Hydromorphone and the risk of infective endocarditis among people who inject drugs: a population-based, retrospective cohort study","volume":"20","author":"Silverman","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ccc.2020.07.006_bib64","doi-asserted-by":"crossref","first-page":"e0219777","DOI":"10.1371\/journal.pone.0219777","article-title":"A\u00a0controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk","volume":"14","author":"Kasper","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib65","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12879-018-3408-y","article-title":"Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study","volume":"18","author":"Gray","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/M18-2124","article-title":"Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data","volume":"170","author":"Schranz","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ccc.2020.07.006_bib67","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1503\/cmaj.180694","article-title":"The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis","volume":"191","author":"Weir","year":"2019","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.ccc.2020.07.006_bib68","doi-asserted-by":"crossref","first-page":"ofaa045","DOI":"10.1093\/ofid\/ofaa045","article-title":"Rural-Urban differences in hospitalizations for opioid use-associated infective endocarditis in the United States, 2003-2016","volume":"7","author":"Nenninger","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"22","key":"10.1016\/j.ccc.2020.07.006_bib69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.15585\/mmwr.mm6722a2","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among persons who inject drugs - six sites, 2005-2016","volume":"67","author":"Jackson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"10.1016\/j.ccc.2020.07.006_bib70","first-page":"443","article-title":"Community outbreak of HIV infection linked to injection drug use of oxymorphone--Indiana, 2015","volume":"64","author":"Conrad","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18_suppl_3","key":"10.1016\/j.ccc.2020.07.006_bib71","doi-asserted-by":"crossref","first-page":"S685","DOI":"10.1161\/CIRCULATIONAHA.110.970939","article-title":"Part 5: adult basic life support","volume":"122","author":"Berg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2020.07.006_bib72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccc.2020.07.006_bib73","unstructured":"Colorado Hospital Association, Colorado Chapter of American College of Emergency Physicians, Colorado Consortium for Prescription Drug Abuse Prevention, et al. 2017 Colorado Opioid Safety Pilot Results Report. Greenwood Village (CO): Colorado Hospital Association; 2018. Available at: https:\/\/cha.com\/wp-content\/uploads\/2018\/06\/CHA-Opioid-Pilot-Results-Report-May-2018.pdf. Accessed June 26, 2020."},{"key":"10.1016\/j.ccc.2020.07.006_bib74","unstructured":"Colorado Hospital Association. Colorado ALTO Project: Clinician Training Materials. Greenwood Village (CO): Colorado Hospital Association; 2020. Available at: https:\/\/cha.com\/wp-content\/uploads\/2018\/04\/Colorado-ALTO-Project-Clinician-Toolkit.pdf. Accessed June 26, 2020."},{"key":"10.1016\/j.ccc.2020.07.006_bib75","unstructured":"Colorado Hospital Association. Colorado ALTO Project: Nurse Training Materials. Greenwood Village (CO): Colorado Hospital Association; 2020. Available at: https:\/\/cha.com\/wp-content\/uploads\/2018\/04\/Colorado-ALTO-Project-Nursing-Toolkit.pdf. Accessed June 26, 2020."},{"issue":"6","key":"10.1016\/j.ccc.2020.07.006_bib76","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","article-title":"Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice","volume":"90","author":"Berna","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ccc.2020.07.006_bib78","unstructured":"Centers for Disease Control and Prevention. Pocket Guide: Tapering Opioids for Chronic Pain. Atlanta (GA): CDC; 2016. Available at: https:\/\/www.cdc.gov\/drugoverdose\/pdf\/clinical_pocket_guide_tapering-a.pdf. Accessed June 26, 2020."},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-year mortality of patients after emergency department treatment for nonfatal opioid\u00a0overdose","volume":"75","author":"Weiner","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13722-017-0083-z","article-title":"Screening, treatment initiation, and referral for substance use disorders","volume":"12","author":"Bernstein","year":"2017","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"10.1016\/j.ccc.2020.07.006_bib81","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention","volume":"32","author":"D'Onofrio","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.ccc.2020.07.006_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ccc.2020.07.006_bib83","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.annemergmed.2018.11.032","article-title":"Managing opioid withdrawal in the emergency department with buprenorphine","volume":"73","author":"Herring","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib84","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajem.2018.10.013","article-title":"Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting","volume":"37","author":"Cisewski","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.ccc.2020.07.006_bib85","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ajem.2019.158373","article-title":"Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program","volume":"38","author":"Kaucher","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.annemergmed.2019.08.420","article-title":"Treating opioid withdrawal with buprenorphine in a community hospital emergency department: an outreach program","volume":"75","author":"Edwards","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"15","key":"10.1016\/j.ccc.2020.07.006_bib87","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2020.07.006_bib88","series-title":"Increasing number of states require naloxone to be co-prescribed with opioids. ASTHO Experts Blog","author":"ASTHO","year":"2019"},{"issue":"6","key":"10.1016\/j.ccc.2020.07.006_bib89","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.5811\/westjem.2018.8.38829","article-title":"The emergency department as an opportunity for naloxone distribution","volume":"19","author":"Gunn","year":"2018","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.ccc.2020.07.006_bib90","first-page":"E271","article-title":"Integration of pharmacy interns in the discharge counseling of intranasal naloxone rescue kits in the emergency department","volume":"34","author":"Shaw","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.ccc.2020.07.006_bib91","first-page":"28","article-title":"The overdose education and naloxone distribution program at a VA hospital","volume":"33","author":"Peckham","year":"2016","journal-title":"Fed Pract"},{"issue":"1","key":"10.1016\/j.ccc.2020.07.006_bib92","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/08897077.2015.1129528","article-title":"Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs","volume":"37","author":"Oliva","year":"2016","journal-title":"Subst Abus"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070420300488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070420300488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:12:22Z","timestamp":1760062342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070420300488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0749070420300488"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2020.07.006","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the Opioid Epidemic","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}